S100A10 and pancreatic adenocarcinoma: Additionally, in Logsdon’s datasets, S100A10/A11 were overexpressed in pancreatic adenocarcinoma (fold change = 7.58 and 18.29), and pancreatitis (fold change = 2.97 and 5.45) compared to normal samples.